Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-002592
Filing Date
2015-05-06
Accepted
2015-05-06 17:25:51
Documents
14
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050615.htm 10-Q 1034467
2 EXHIBIT 10.1 exh_101.htm EX-10.1 472974
3 EXHIBIT 10.2 exh_102.htm EX-10.2 116343
4 EXHIBIT 10.3 exh_103.htm EX-10.3 543818
5 EXHIBIT 31.1 exh_311.htm EX-31.1 14692
6 EXHIBIT 31.2 exh_312.htm EX-31.2 14620
7 EXHIBIT 32.1 exh_321.htm EX-32.1 6261
8 EXHIBIT 32.2 exh_322.htm EX-32.2 6345
  Complete submission text file 0001171843-15-002592.txt   7331967

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT tkmr-20150331.xml EX-101.INS 974014
10 XBRL TAXONOMY EXTENSION SCHEMA tkmr-20150331.xsd EX-101.SCH 46308
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tkmr-20150331_cal.xml EX-101.CAL 21391
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tkmr-20150331_def.xml EX-101.DEF 196717
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE tkmr-20150331_lab.xml EX-101.LAB 291875
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tkmr-20150331_pre.xml EX-101.PRE 199432
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 15838363
SIC: 2834 Pharmaceutical Preparations